Jounce Therapeutics is an immunotherapy company developing therapies to cancer founded in 2013 by James P. Allison, Drew Pardoll, Louis M. Weiner, Padmanee Sharma, Robert D. Schreiber and Thomas F. Gajewski.
Currently, there are no issues on this topic.